Literature DB >> 19061103

A case against justified non-voluntary active euthanasia (the Groningen Protocol).

Alan Jotkowitz1, S Glick, B Gesundheit.   

Abstract

The Groningen Protocol allows active euthanasia of severely ill newborns with unbearable suffering. Defenders of the protocol insist that the protocol refers to terminally ill infants and that quality of life should not be a factor in the decision to euthanize an infant. They also argue that there should be no ethical difference between active and passive euthanasia of these infants. However, nowhere in the protocol does it refer to terminally ill infants; on the contrary, the developers of the protocol take into account the future quality of life of the infant. We also note how the Nazi Euthanasie Programm started with the premise that there is some life not worthy of living. Therefore, in our opinion, the protocol violates the traditional ethical codes of physicians and the moral values of the overwhelming majority of the citizens of the world.

Entities:  

Mesh:

Year:  2008        PMID: 19061103     DOI: 10.1080/15265160802513085

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


  4 in total

1.  Dutch Protocols for Deliberately Ending the Life of Newborns: A Defence.

Authors:  Matthew Tedesco
Journal:  J Bioeth Inq       Date:  2017-02-20       Impact factor: 1.352

Review 2.  Medical assistance in dying: A paediatric perspective.

Authors:  Dawn Davies
Journal:  Paediatr Child Health       Date:  2018-04-12       Impact factor: 2.253

3.  Physician-hastened death in young children: Getting to underlying assumptions.

Authors:  Lester Liao; Daniel Chan
Journal:  Paediatr Child Health       Date:  2016-05       Impact factor: 2.253

4.  Attitudes among the general Austrian population towards neonatal euthanasia: a survey.

Authors:  Lena Goldnagl; Wolfgang Freidl; Willibald J Stronegger
Journal:  BMC Med Ethics       Date:  2014-10-07       Impact factor: 2.652

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.